Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Context: A majority of women with polycystic ovary syndrome (PCOS) have metabolic abnormalities that result in an increased risk of developing type 2 diabetes and heart disease. Correlative studies have shown an association between changes in the gut microbiome and metabolic disorders. Two recent studies reported a decrease in α diversity of the gut microbiome in women with PCOS compared with healthy women. Objective: We investigated whether changes in the gut microbiome correlated with specific clinical parameters in women with PCOS compared with healthy women. We also investigated whether there were changes in the gut microbiome in women with polycystic ovarian morphology (PCOM) who lacked the other diagnostic criteria of PCOS. Participants: Subjects were recruited at the Poznan University of Medical Sciences. Fecal microbial diversity profiles of healthy women (n = 48), women with PCOM (n = 42), and women diagnosed with PCOS using the Rotterdam criteria (n = 73) were analyzed using 16S ribosomal RNA gene sequencing. Results: Lower α diversity was observed in women with PCOS compared with healthy women. Women with PCOM had a change in α diversity that was intermediate between that of the other two groups. Regression analyses showed that hyperandrogenism, total testosterone, and hirsutism were negatively correlated with α diversity. Permutational multivariate analysis of variance in UniFrac distances showed that hyperandrogenism was also correlated with β diversity. A random forest identified bacteria that discriminated between healthy women and women with PCOS. Conclusion: These results suggest that hyperandrogenism may play a critical role in altering the gut microbiome in women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In keeping with the developmental origins hypothesis previously discussed, maternal androgens may alter the composition and function of the microbiome, therefore facilitating the pathogenesis of PCOS [140].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although most studies are small, dysbiosis has consistently been found to correlate with different physiological parameters, such as obesity, sex hormones and metabolic defects [140,141,143].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One study showed that beta diversity, which is used to measure differences between groups, was negatively correlated with hyperandrogenism, suggesting that androgens play a significant role in dysbiosis [140].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Decreased α-diversity has been described in women with PCOS [109, 110].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [110]
The cited source says what the claim attributes to it.
In the citing paper
“Dysbiosis is a consistent finding when looking at the microbiome of women with PCOS [140,141,142,143].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb01338.x · Cited by 88,486
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb00917.x · Cited by 48,949
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209 · cited 1×
“The resulting SVs were then aligned using MAFFT (21), and a phylogenetic tree was built using FastTree (22).”
MethodDADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698 · cited 1×
“DADA2 software was used to obtain a set of observed sequence variants (SVs) (19).”
MethodQIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · cited 1×
“6/) (18) using the q2-tools-import script, and sequences were demultiplexed using the q2-demux emp-single script.”
MethodSelf-citationAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Fecal microbiome transplantation from obese humans into germ-free mice also resulted in an obese phenotype, indicating a potential causative role of the gut microbiome in the development of metabolic disorders (13, 14).”
BackgroundUltra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839 · cited 1×
“For each sample, the V4 hypervariable region of the 16S ribosomal RNA (rRNA) gene was polymerase chain reaction (PCR) amplified with primers 515F and 806R (16).”
MethodHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Cited by
Items 101–200 of 414
Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments
García-Beltrán, C., Malpique, R., Carbonetto, B., González‐Torres, P., Henares, D., Brotons, P., Muñoz‐Almagro, C., López‐Bermejo, A., de Zegher, F., & Ibáñez, L. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12734 · Cited by 49
Salehi, S., Allahverdy, J., Pourjafar, H., Sarabandi, K., & Jafari, S. M. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10223-5 · Cited by 51
“Also, a positive correlation has been observed between Bacteroidetes , Escherichia , Shigella , and Streptococcus with testosterone levels and a negative correlation between them and Akker-mansia with ghrelin [75, 85, 88–90].”
Huang, F., Deng, Y., Zhou, M., Tang, R., Zhang, P., & Chen, R. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03513-z · Cited by 49
“Several studies have reported that individuals with PCOS have gut microbiota communities different from those of healthy controls [13, 14, 57, 58]; however, we did not perform 16 S rRNA analysis on patient samples.”
BackgroundXiao, L., Zuo, Z., & Zhao, F. (2023) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzad005 · Cited by 51
Zhou, Z., Feng, Y., Xie, L., Ma, S., Cai, Z., & Ma, Y. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01184-z · Cited by 47
“Regarding the diversity of the gut microbiome, 24 studies reported the Shannon index in patients (n = 929) and controls (n = 1042) [22, 25, 26, 28, 29, 31–49].”
BackgroundPolycystic Ovary Syndrome and Psychotic Disorder
Doretto, L., Mari, F. C., & Chaves, A. C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00543 · Cited by 52
“(13) have suggested that hyperandrogenism may play a direct role in altering the gut microbiome of women with PCOS.”
BackgroundSingh, V., Mahra, K., Jung, D.-R., & Shin, J. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10262-y · Cited by 47
Rambaran, N., & Islam, M. S. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i7.108789 · Cited by 48
Zhao, H., Chen, R., Zheng, D., Xiong, F., Jia, F., Liu, J., Zhang, L., Zhang, N., Zhu, S., Liu, Y., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854796 · Cited by 45
Parker, J., O'Brien, C., & Hawrelak, J. (2022) · Obstetrics & Gynecology Science · doi:10.5468/ogs.21185 · Cited by 42
“Dysbiosis We identified 14 human studies that compared the microbiota of patients diagnosed with PCOS with a variety of control groups [29-42].”
BackgroundResultLiyanage, G. I. M., Inoüe, R., Fujitani, M., Ishijima, T., Shibutani, T., Abe, K., Kishida, T., & Okada, S. (2021) · Nutrients · doi:10.3390/nu13113759 · Cited by 45
“These studies also analyzed the overall composition of gut microbiota and have found changes in bacterial genera in women with PCOS compared to healthy/control individuals [4,40,41,43,44].”
BackgroundUnraveling the gut microbiota’s role in PCOS: a new frontier in metabolic health
Li, C., Cheng, D., Ren, H., & Zhang, T. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529703 · Cited by 48
Su, Y.-N., Wang, M., Yang, J.-P., Wu, X.-L., Xia, M., Bao, M., Ding, Y., Feng, Q., & Fu, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1122709 · Cited by 47
Li, J., Qiao, J., Li, Y., Qin, G., Xu, Y., Lao, K., Wang, Y., Yang, F., Tang, P., & Han, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1526468 · Cited by 45
Patel, J. K., Chaudhary, H., Rajput, K. N., Parekh, B., & Joshi, R. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-39168-5 · Cited by 41
“In keeping with the literature (14), the study found that women with PCOS had lower levels of estradiol and much higher levels of testosterone than the control group.”
BackgroundSola‐Leyva, A., Pérez‐Prieto, I., Molina, N. M., Vargas, E., Ruíz-Durán, S., Leonés-Baños, I., Canha-Gouveia, A., & Altmäe, S. (2023) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2023.03.016 · Cited by 43
He, Y., Wang, Q., Xiu, L., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2021) · Food & Function · doi:10.1039/d1fo90033a · Cited by 39
Butyrate as a Potential Modulator in Gynecological Disease Progression
Kim, N., & Yang, C. (2024) · Nutrients · doi:10.3390/nu16234196 · Cited by 41
Gut microbiota: an emerging target connecting polycystic ovarian syndrome and insulin resistance
Mei, Y., Li, W., Wang, B., Chen, Z., Wu, X., Lin, Y., & Wang, M. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1508893 · Cited by 43
“Torres (Torres et al., 2018) found in humans that reduced a -diversity negatively correlates with androgen levels and that hyperandrogenism is closely linked to changes in overall bacterial composition, indicated by b -diversity.”
Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome
Li, N., Li, Y., Qian, C., Liu, Q., Cao, W., Ma, M., He, R., Chen, R., Geng, R., & Liu, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.624504 · Cited by 42
“, 2018), but inconsistent with some other studies (Liu et al., 2017; Torres et al., 2018) that reported reductions in the alpha and beta diversity indexes in PCOS patients compared with controls.”
BackgroundResultInfluentialEffects of intestinal flora on polycystic ovary syndrome
Liu, J., Liu, Y., & Li, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1151723 · Cited by 44
“It was found that serum testosterone and hirsutismwere negatively correlated witha diversity offlora (33, 34), while the level of free testosterone was correlated to the ratio of Firmicutes/Bacteroidetes (35).”
BackgroundXiong, C., Wu, J., Ma, Y., Li, N., Wang, X., Li, Y., & Ding, X. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s451129 · Cited by 38
“32 35 In our study, the beta diversity and abundance of the gut microbiota were decreased in the PCOS group by enriching the phylum Bacteroidota, which contributed to a reduced ratio of Bacillota to Bacteroidota.”
BackgroundBifidobacterium Is Enriched in Gut Microbiome of Kashmiri Women with Polycystic Ovary Syndrome
Hassan, S., Kaakinen, M., Draisma, H. H. M., Zudina, L., Ganie, M. A., Rashid, A., Balkhiyarova, Z., Kiran, G. S., Vogazianos, P., Shammas, C., et al. (2022) · Genes · doi:10.3390/genes13020379 · Cited by 41
“This is a unique finding as previous studies showed decreased diversity among individuals with PCOS as compared to without [53,54] and our observation may be specific to the Kashmiri population.”
BackgroundResultMin, Q., Geng, H., Gao, Q., & Xu, M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1203902 · Cited by 39
“, 2021), 5 taxa decreased (Torres et al., 2018; Zhang et al., 2019), and one taxon (Faecalibacterium prausnitzii) showed inconsistent results in three studies (Torres et al.”
BackgroundResultCheng, Q., Lv, S., Yin, N., & Wang, J. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00839-y · Cited by 36
Calcaterra, V., Magenes, V. C., Massini, G., De Sanctis, L., Fabiano, V., & Zuccotti, G. (2024) · Nutrients · doi:10.3390/nu16070938 · Cited by 35
Use of contraceptives and risk of inflammatory bowel disease: a nested case–control study
Pasvol, T. J., Bloom, S. L., Segal, A. W., Rait, G., & Horsfall, L. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16647 · Cited by 40
The effect of the female genital tract and gut microbiome on reproductive dysfunction
Cao, W., Fu, X., Zhou, J., Qi, Q., Ye, F., Li, L., & Wang, L. (2023) · BioScience Trends · doi:10.5582/bst.2023.01133 · Cited by 38
The gut microbiota: emerging biomarkers and potential treatments for infertility-related diseases
Wang, M., Zheng, L., Ma, S., Zhao, D.-H., & Xu, Y. D. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1450310 · Cited by 36
Huang, X., Geng, H., Liang, C., Xiong, X., Du, X., Zhuan, Q., Liu, Z., Lin, M., Zhou, D., Zhang, L., et al. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.11.021 · Cited by 34
Babu, A., Rajeswari, V. D., Ganesh, V., Das, S., Sivaraman, D., Rani, G. U., & Ramanathan, G. (2024) · Reproductive Sciences · doi:10.1007/s43032-023-01450-2 · Cited by 34
“To evaluate the microbial diversity among obese women with/without PCOS, non-obese women with PCOS, and controls, a study was undertaken that revealed that obese and non-obese PCOS women had different β-diversity levels [68].”
Chudzicka-Strugała, I., Kubiak, A., Banaszewska, B., Zwoździak, B., Siakowska, M., Pawelczyk, L. A., & Dulęba, A. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab369 · Cited by 37
Self-citationZhu, X., Li, Y., Jiang, Y., Zhang, J., Duan, R., Liu, L., Liu, C., Xu, X., Yu, L., Wang, Q., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.665406 · Cited by 32
Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions
Zhao, Q., Wu, J., Ding, Y., Pang, Y., & Jiang, C. (2023) · Life Metabolism · doi:10.1093/lifemeta/load032 · Cited by 35
Zhang, F., Ma, T., Tong, X., Liu, Y., Cui, P., Xu, X., Shi, J., Hu, W., Lu, W., Pei, Z., et al. (2021) · Acupuncture in Medicine · doi:10.1177/09645284211056663 · Cited by 37
Female infertility in the era of obesity: The clash of two pandemics or inevitable consequence?
Medenica, S., Spoltore, M. E., Ormazabal, P., Marina, L., Šojat, A. S., Faggiano, A., Gnessi, L., Mazzilli, R., & Watanabe, M. (2022) · Clinical Endocrinology · doi:10.1111/cen.14785 · Cited by 32
“and Torres et al.(51) However, Qi et al.”
BackgroundInfluentialTrends in metabolic dysfunction in polycystic ovary syndrome: a bibliometric analysis
Xu, Y., Cao, Z., Chen, T., & Ren, J. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1245719 · Cited by 34
Hariri, Z., Yari, Z., Hoseini, S., Abhari, K., & Sohrab, G. (2024) · BMC Women s Health · doi:10.1186/s12905-023-02868-1 · Cited by 33
“Altered gut microbiota in women with PCOS has been reported in several studies, which can cause a decrease in short-chain fatty acids (SCFA) production [15, 49, 50].”
BackgroundCutillas-Tolín, A., Árense-Gonzalo, J. J., Mendiola, J., Adoamnei, E., Navarro-Lafuente, F., Sánchez-Ferrer, M. L., Prieto‐Sánchez, M. T., Carmona‐Barnosi, A., Vioqué, J., & Torres-Cantero, A. M. (2021) · Nutrients · doi:10.3390/nu13020313 · Cited by 35
Role of Biological Sex in the Cardiovascular-Gut Microbiome Axis
Li, S., & Kararigas, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.759735 · Cited by 29
Vaginal microbiome in obesity and its impact on reproduction
Garg, A., Ellis, L. B., Love, R. L., Grewal, K. J., Bowden, S. J., Bennett, P. R., & Kyrgiou, M. (2023) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102365 · Cited by 31
Role of polyphenols in remodeling the host gut microbiota in polycystic ovary syndrome
Zhou, P., Feng, P., Liao, B., Fu, L. N., Shan, H., Cao, C., Luo, R., Peng, T., Liu, F.-T., & Li, R. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01354-y · Cited by 28
“Studies have analyzed women with PCOS [4–6] and animal models of PCOS [4, 7, 8] to report that there exists a significant difference in the composition of intestinal flora between those with PCOS versus normal controls.”
BackgroundSun, J., Wang, M., & Kan, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1280983 · Cited by 31
Zhang, H., Zheng, L., Li, C., Jing, J., Li, Z., Sun, S., Xue, T., Zhang, K., Xue, M., Cao, C., et al. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01227-w · Cited by 27
Zhang, Y., Chen, M., Li, Y., Guo, Y., Yu, Y., Zhi, Z., Hui, L., Si, Y., Wu, C., Zhang, X., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1457467 · Cited by 31
Chen, X., Zhang, D., Sun, H., Jiang, F., Shen, Y., Wei, P., & Shen, X. (2021) · PeerJ · doi:10.7717/peerj.11439 · Cited by 34
“reported that Bacteroides coprophilus increased in women with polycystic ovary syndrome, which was usually accompanied by obesity (Torres et al., 2018).”
BackgroundZhang, S., He, H., Wang, Y., Wang, X., & Liu, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-34746-z · Cited by 30
Zou, Y., Liao, R., Cheng, R., Chung, H., Zhu, H., & Huang, Y. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106370 · Cited by 29
Li, Y., Zhu, Y., Li, D., Liu, W., Zhang, Y., Liu, W., Zhang, C., & Tao, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265152 · Cited by 28
Precision medicine in perinatal depression in light of the human microbiome
Bernabé, B. P., Maki, P. M., Dowty, S. M., Salas, M. L. C., Cralle, L. E., Shah, Z., & Gilbert, J. A. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05436-4 · Cited by 31
“2016) and other autoimmune diseases (Maeda and Takeda 2017), polycystic ovarian syndrome (Torres et al. 2018), infertility (Moreno et al.”
BackgroundInfluentialHuffman, A. M., Rezq, S., Basnet, J., Cardozo, L. L. Y., & Romero, D. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094472 · Cited by 27
“A number of recent studies indicate that women with PCOS have a different gut microbiome composition than healthy women and hyperandrogenism is a primary driver of dysbiosis in women with PCOS [61,62].”
BackgroundZhou, M., Yu, J., Li, X., Ruan, Z., & Yu, S. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18258 · Cited by 27
“18 At present, research on the relationship between PCOS and gut microbiota is mostly focused on PCOS patients who meet the Rotterdam diagnostic criteria, and there is a lack of classification research for different subtypes of PCOS patients.”
BackgroundA review of metabolic and microbial influences on women with polycystic ovarian syndrome
Ravat, F. K., Goswami, J., Nair, S. M., & Thummar, K. N. (2024) · Steroids · doi:10.1016/j.steroids.2024.109512 · Cited by 28
Chudzicka-Strugała, I., Kubiak, A., Banaszewska, B., Wysocka, E., Zwoździak, B., Siakowska, M., Pawelczyk, L. A., & Dulęba, A. J. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07833-3 · Cited by 28
“Subjects of the present study had two important risk factors for adverse gut microbiome (i.e., dysbiosis): obesity and PCOS [25, 26, 38, 45].”
Self-citationBlood Bacterial 16S rRNA Gene Alterations in Women With Polycystic Ovary Syndrome
Wang, Q., Wang, Q., Zhao, L., Bin, Y., Wang, L., Wang, L., Zhang, K., & Li, Q. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.814520 · Cited by 26
“Our study discovered a significantly lower abundance of blood Ruminococcaceae of PCOS patients, which was consistent with some other gut microbiota studies (17, 19).”
BackgroundResultMathew, M., Sivaprakasam, S., Phy, J. L., Bhutia, Y. D., & Ganapathy, V. (2023) · Bioscience Reports · doi:10.1042/bsr20212234 · Cited by 27
Uddandrao, V. V. S., Naidu, P. B., Chandrasekaran, P., & Saravanan, G. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01411-4 · Cited by 31
“Several human studies report an alteration in the overall composition of gut bacteria in women suffering from PCOS, with a decrease in the number of different species in a given sample, alpha diversity, and changes in the similarity of one sample to another, beta diversity [91].”
Polycystic ovary syndrome: Recent research and therapeutic advancements
Dilliyappan, S., Kumar, A. S., Venkatesalu, S., Palaniyandi, T., Baskar, G., Sivaji, A., Rab, S. O., Saeed, M., & Shivaranjani, K. S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123221 · Cited by 29
Li, M., Chang, Q., Luo, Y., Pan, J., Hu, Y., Liu, B., Ma, M., Wang, Q., Guo, Y. M., & Wang, Q. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1384233 · Cited by 28
Gautam, R., Maan, P., Patel, A. K., Vasudevan, S., & Arora, T. K. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.10.028 · Cited by 28
Don’t Trust Your Gut: When Gut Microbiota Disrupt Fertility
Silva, M. S. B., & Giacobini, P. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.005 · Cited by 25
Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: A review
Guo, H., Luo, J., & Lin, H. (2023) · Medicine · doi:10.1097/md.0000000000036075 · Cited by 28
Reshaping the Gut Microbiota Through Lifestyle Interventions in Women with PCOS: A Review
Ramadurai, S., & Balasundaram, U. (2022) · Indian Journal of Microbiology · doi:10.1007/s12088-022-01019-8 · Cited by 24
“Polycystic ovarian morphology (PCOM) (n = 42), control (n = 48) and PCOS (n = 73) Poland ;Alpha diversity in PCOS than controls :Porphyromonas, Bacteroides, Blautia, Faecalibacterium, Prausnitzii [120] 352 Indian J Microbiol (July–Sept 2022) 62(3):351–363”
BackgroundRani, K., Kaur, G., & Ali, S. A. (2023) · PharmaNutrition · doi:10.1016/j.phanu.2023.100342 · Cited by 25
Emerging pollutants in etiology and pathophysiology of polycystic ovary syndrome
Gautam, R., Parambil, A. M., Patel, A. K., & Arora, T. K. (2023) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108515 · Cited by 28
Ni, Z., Cheng, W., Ding, J., Yao, R., Zhang, D., Zhai, D., Zhou, L., & Yu, C. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6671367 · Cited by 26
Zhu, Q., & Zhang, N. (2024) · Reproductive Sciences · doi:10.1007/s43032-023-01440-4 · Cited by 24
“Eight studies [19, 22, 23, 26, 29, 36, 38, 47] found a significant difference in the phylogenetics of gut microbiota between PCOS patients and controls, whereas thirteen studies did not show a clear separation of PCOS from healthy controls.”
Effect of High-Fat Diet on the Intestinal Flora in Letrozole-Induced Polycystic Ovary Syndrome Rats
Zheng, Y., Xu, Y., Ma, H., Liang, C., & Yang, T. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6674965 · Cited by 25
The Kynurenine Pathway and Polycystic Ovary Syndrome: Inflammation as a Common Denominator
Jovanović, F., Sudhakar, A., & Knežević, N. N. (2022) · International Journal of Tryptophan Research · doi:10.1177/11786469221099214 · Cited by 23
Exploiting conjugated linoleic acid for health: a recent update
Chen, Y., Xiao, J., Zhu, X., Fan, X., Peng, M., Yang, M., Wang, C., Xia, L., & Zhou, M. (2024) · Food & Function · doi:10.1039/d4fo04911j · Cited by 24
Kumar, A., Sakhare, K. R., Bhattacharya, D., Chattopadhyay, R., Parikh, P. M., Narayan, K. P., & Mukherjee, A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.966152 · Cited by 30
“Studies showed that the diversity of gut microbes in patients with PCOS is significantly reduced compared with control groups (84).”
BackgroundBubnov, R. V., & Spivak, M. Y. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-19564-8_6 · Cited by 24
Yue, F., Lin, X., Wu, S., Lin, W., Zhou, Z., Shi, Y., Lam, S. M., Shui, G., Xiang, X., Russell, R., et al. (2022) · Obesity · doi:10.1002/oby.23380 · Cited by 22
“had decreased α- diversity compared with NDfed rats, and HFD- LL rats showed a further decrease in α- diversity (microbial richness) than HFD- LD rats, which is consistent with findings that have demonstrated that decreased α- diversity was observed in PCOS women and was correlated with obesity and hyperandrogenemia (…”
ResultPharmacological strategies for sexual recovery in men undergoing antipsychotic treatment
Jannini, T. B., Sansone, A., Rossi, R., Lorenzo, G. D., Toscano, M., Siracusano, A., & Jannini, E. A. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2071124 · Cited by 24
Wang, X., Gu, L., Zhang, Y., Xiong, C., Peng, Y., & Ding, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1030151 · Cited by 23
“reported a relationship between the gut microbiota and hyperandrogenism, although the genesis is still unclear (15).”
BackgroundCharacterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia
Yang, T., Li, G., Xu, Y., He, X., Song, B., & Cao, Y. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03329-x · Cited by 22
“In the past decade, research has established a correlation between gut microbiota and the clinical manifestations of PCOS as well as its metabolic complications [17, 26, 27].”
BackgroundHo, B., Ryback, D., Benson, B., Mason, C. N., Torres, P. J., Quinn, R. A., Thackray, V. G., & Kelley, S. T. (2021) · mSystems · doi:10.1128/msystems.01149-20 · Cited by 21
“longitudinal relationship of the gut microbiome samples collected in the letrozoleinduced PCOS-like mouse model cohousing study (22).”
Self-citationYang, L., Liu, T., Liao, Y., Ren, Y., Zheng, Z., Zhang, M., Yu, Y., Liu, C., Wang, C., Chen, T., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117504 · Cited by 21
Early-life gut inflammation drives sex-dependent shifts in the microbiome-endocrine-brain axis
Sullivan, O., Sie, C., Ng, K. M., Cotton, S., Rosete, C., Hamden, J. E., Singh, A. P., Lee, K., Choudhary, J., Kim, J. A., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.003 · Cited by 20
Polycystic Ovary Syndrome and Gut Microbiota: Phenotype Matters
Сутурина, Л. В., Belkova, N. L., Igumnov, I., Лазарева, Л. М., Николаевна, Д. И., Nadeliaeva, I. G., Sholokhov, L. F., Рашидова, М. А., Belenkaya, L., Владимирович, Б. А., et al. (2022) · Life · doi:10.3390/life13010007 · Cited by 22
“We have found only a few references where the associations of alpha diversity indexes with clinical, hormonal, or metabolic parameters were investigated [10,26,33].”
BackgroundBai, X., Ma, J., Wu, X., Qiu, L., Huang, R., Zhang, H., Huang, H., & Chen, X. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s388067 · Cited by 23
“Recent studies have reported alterations of gut microbiota in PCOS patients and provided convincing evidence for a causal correlation between dysbiosis of gut microbiota and onset of ovarian and metabolic dysfunction.(2,4) Dysbiosis of gut microbiota can increase secretion of ovarian androgen, which then interfere nor…”
ResultSrivastava, S., Mishra, S., Babu, G., & Mohanty, B. (2023) · Reproductive Biology · doi:10.1016/j.repbio.2023.100828 · Cited by 20
Interplay between PCOS and microbiome: The road less travelled
Batra, M., Bhatnager, R., Kumar, A., Suneja, P., & Dang, A. S. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13580 · Cited by 23
Pan, L., Xie, L., Zheng, H., Feng, Y., Mai, F., Tang, W., Wang, J., Lan, Z., Lv, S., Jayawardana, T. C., et al. (2025) · iMeta · doi:10.1002/imt2.70065 · Cited by 19
“Recent research has revealed that gut microbiota and its metabolites contribute significantly to the pathogenesis of PCOS [6 – 9].”
Zhang, N., Li, C., Guo, Y. Q., & Wu, H. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/6389034 · Cited by 19
“Studies have found that, compared with healthy women, women with PCOS have lower alpha diversity [14].”
BackgroundMetagenomic-based characterization of the gut virome in patients with polycystic ovary syndrome
Huang, L., Wu, X., Guo, S., Lv, Y., Zhou, P., Huang, G., Duan, Z., & Sun, W. C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.951782 · Cited by 20
“There is abundant evidence that the gut microbiota contributes significantly to the development of PCOS (Liu et al., 2017; Torres et al., 2018; Qi et al., 2019).”
BackgroundKamenov, Z. A., Gateva, A., Dinicola, S., & Unfer, V. (2023) · Metabolites · doi:10.3390/metabo13060717 · Cited by 19
“Furthermore, women with PCOS compared with healthy women have a lower α-diversity of the gut microbiome, which negatively correlates with hyperandrogenism, total testosterone, and hirsutism [35].”
BackgroundHarada, N., Minami, Y., Hanada, K., Hanaoka, R., Kobayashi, Y., Izawa, T., Sato, T., Kato, S., Inui, H., & Yamaji, R. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1817719 · Cited by 19
“Changes in gut microbiota and reduced α-diversity in PCOS patients have been reported.(32,44) Notably, the transplantation of fecal microbiota has been reported to be beneficial for PCOS.”
BackgroundBarraza-Ortega, E., Gómez‐Gil, B., García-Gasca, T., Lizárraga, D., Díaz, N., & García-Gasca, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178574 · Cited by 21
“This syndrome is closely associated with IR and a low-grade inflammatory state, in which the gut microbiome plays a mediating role [60].”
Annunziata, G., Ciampaglia, R., Capó, X., Guerra, F., Sureda, A., Tenore, G. C., & Novellino, E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112171 · Cited by 18
Ji, X., Chen, J., Xu, P., Shen, S., & Bi, Y. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2119219 · Cited by 20
“Emerging evidence have found distinctive differences in the diversity and composition of gut microbiome between healthy and PCOS groups [9].”
BackgroundBorzan, V., Riedl, R., & Obermayer-Pietsch, B. M. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01294-6 · Cited by 20
“The decreased alpha diversity of the gut microbiome has been found to correlate to total testosterone levels as well as the degree of hirsutism [7], while also being linked with insulin resistance, dyslipidemia as well as obesity [9, 10].”
BackgroundResultLin, Y., Zeng, H., Lin, J., Peng, Y., Que, X., Wang, L., Chen, L., & Bai, N. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1328741 · Cited by 18
Wang, Z., Fu, H., Zhou, Y., Yan, M., Chen, D., Yang, M. J., Xiao, S., Chen, C., & Huang, L. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13695 · Cited by 19
“These bacteria are associated with the regulation of sex hormones (Moreno-Indias et al., 2016; Liu et al. 2017a; Torres et al., 2018; Thackray, 2019).”
BackgroundPositive Effects of α-Lactalbumin in the Management of Symptoms of Polycystic Ovary Syndrome
Cardinale, V., Lepore, E., Basciani, S., Artale, S. A., Nordio, M., Bizzarri, M., & Unfer, V. (2022) · Nutrients · doi:10.3390/nu14153220 · Cited by 19
“Such alteration reflects changes in the composition of the microbial community, with differences in the relative abundance of specific phyla like Firmicutes and Bacteroidetes [33,34].”
BackgroundInfluentialSexual Dimorphic Interplays Between Gut Microbiota and Antihypertensive Drugs
Bardhan, P., & Yang, T. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01244-6 · Cited by 18
Sex Hormones, the Stool Microbiome, and Subclinical Atherosclerosis in Women With and Without HIV
Peters, B. A., Hanna, D. B., Wang, Y., Weber, K. M., Topper, E., Appleton, A. A., Sharma, A., Hodis, H. N., Santoro, N. F., Guillemette, C., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad510 · Cited by 19
Leung, W. T., Tang, Z., Feng, Y., Guan, H., Huang, Z., & Zhang, W. (2022) · Nutrients · doi:10.3390/nu14245285 · Cited by 17
Prakash, A., Nourianpour, M., Senok, A. C., & Atiomo, W. (2022) · Cells · doi:10.3390/cells11193038 · Cited by 20
“[44] Case-Control study 73 women with PCOS, 43 women with PCOM, and 48 healthy controls 16S rRNA Lower α diversity.”
MethodGut bacteriome and mood disorders in women with PCOS
Lee, S., Tejesvi, M. V., Hurskainen, E., Aasmets, O., Plaza‐Díaz, J., Franks, S., Morin-Papunen, L. C., Tapanainen, J. S., Ruuska, T. S., Altmäe, S., et al. (2024) · Human Reproduction · doi:10.1093/humrep/deae073 · Cited by 18
“…showed a higher abundance of Sutterella (Arroyo et al. , 2019; Zhou et al. , 2020a; Li et al. , 2022), and a reduction of SCFA-producing bacteria (Torres et al. , 2018; Zhang et al. , 2019; Chu et al. , 2020), which influence both inflammation (Peirce and Alvi ~ na, 2019; Silva et al. , 2020; He…”
Metadata
- Authors
- Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G.
- Affiliations
- San Diego State University (US)
- Poznan University of Medical Sciences (PL)
- Department of Reproductive Medicine, University of California, San Diego, La Jolla, California
- University of California San Diego (US)
- Corresponding author
- Thackray, Varykina G
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-01-23
- Volume
- 103
- Issue
- 4
- Pages
- 1502-1511
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6276580
- OpenAlex
- W2792000617
- Cited by
- 399
- References
- 42
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 69 · 2023: 55 · 2022: 44 · 2021: 57 · 2020: 37 · 2019: 20 · 2018: 5
- FWCI
- 31.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD012303, R01HD082567)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- polycystic ovary syndrome, gut microbiota, hyperandrogenism, alpha diversity, beta diversity, polycystic ovary morphology, hirsutism, total testosterone, fecal microbiota, 16S rRNA gene sequencing, type 2 diabetes risk, metabolic disorders
- MeSH terms
- Gastrointestinal Microbiome, Adult, Feces, Female, Humans, Polycystic Ovary Syndrome, RNA, Ribosomal, 16S, Hyperandrogenism, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.